Clinical Trials Advantage

Clinical collaboration with top comprehensive and specialized hospitals in China 

This international multi-center Phase III clinical trial network for C-Cure® has been initiated in Beijing Anzhen Hospital of Capital Medical University and Shanghai East Hospital of Tongji University. Lately, it has been expanded to other top hospitals such as Fuwai Hospital of CAM&PUMC, Shanghai Zhongshan Hospital of Fudan University and ten additional sites in Beijing, Shanghai, Chengdu and Guangzhou.

Medisun plans to establish large-scale production facilities of stem cell therapies  in Northern,Central and Southern China to support the clinical development and commercialization of C-Cure® and other cell-based products.